A pharmacological study of M1151C2
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-jRCT2031210012
- Lead Sponsor
- ishiura Tomoyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Confirmed diagnosis of atopic dermatitis
Patients with a history of, or currently with any of the following diseases:
1) malignact tumor
2) Serious allergy (shock, anaphylactoid symptoms)
3) Allergy to tacrolimus
4) Cutaneous hypersensitivity to topical drugs (e.g., allergic contact dermatitis)
Patients with any of the following diseases:
1) Diseases considered inappropriate for study participation, such as serious cardiac, hepatic, renal, pulmonary, or hematologic diseases
2) Severe renal dysfunction, severe hyperkalemia or symptoms caused by them
3) ulcer or erosion clearly forming a plaque at the application site of the investigational drug
4) Diseases with ichthyosis-like erythroderma (Netherton syndrome, etc.)
5) Skin infections at the application site of the investigational
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method usability of the investigational
- Secondary Outcome Measures
Name Time Method